Research  >  Research  >  Centres  >  Harquail Centre for Neuromodulation  >  Clinical trials
Share:  
|
PAGE
MENU

Clinical trials

We are dedicated to investigating minimally invasive and individualized treatment options for patients who are resistant to standard treatment therapies.

Magnetic resonance guided focused ultrasound (MRgFUS) is a non-invasive, image-guided technology that uses ultrasound energy to target specific areas of the brain and body to treat various diseases. We can use this scalpel free technology to either to create lesions in specific brain areas that are believed to be contributing to a disabling symptom (example, essential tremor) or to temporarily open the blood brain barrier to allow for drug delivery directly to the brain (example for brain tumors).

Deep brain stimulation (DBS) ‘the pace-maker of the brain’ involves implanting electrodes within certain areas of the brain. These electrodes produce electrical signals that help control abnormal brain activity. The amount of stimulation is individualized and controlled by a connected pacemaker-like device placed under the skin in a patient’s upper chest area.

For more information about these and other clinical trials, please click the platform of interest below:

Neurodegenerative disease trials

Parkinson ’s disease, Alzheimer’s disease, Amyotrophic lateral sclerosis, Multiple sclerosis tremor

Psychiatry trials

Obsessive compulsive disorder, Alcohol use disorder, Major depressive disorder, Post-traumatic stress disorder, RTMS, TMS

Oncology trials

Glioblastoma, Recurrent glioblastoma, Metastatic brain tumors, Diffuse intrinsic pontine gliomas

Movement disorders trials

Severe hand tremors/Essential tremors Multiple sclerosis